Creso Pharma Limited announced that its Co-founder and Chief Executive Officer, Dr. Miri Halperin Wernli will transition to the role of Technology, Innovation and Distribution head and continue to serve on the Company's Board of Directors. Transitioning to the role of Technology, Innovation and Distribution head will allow Dr. Halperin Wernli to focus on new technologies for the hemp and cannabis products globally as well as on furthering the commercialization and distribution efforts of the Mernova medical cannabis products.